Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB, RECOMBINANT | Dermatitis psoriasiform | 2 |
| INFLIXIMAB, RECOMBINANT | Diarrhoea | 2 |
| INFLIXIMAB, RECOMBINANT | Disseminated intravascular coagulation | 2 |
| INFLIXIMAB, RECOMBINANT | Drug hypersensitivity | 2 |
| INFLIXIMAB, RECOMBINANT | Drug-induced liver injury | 2 |
| INFLIXIMAB, RECOMBINANT | Embolism | 2 |
| INFLIXIMAB, RECOMBINANT | Exposure during pregnancy | 2 |
| INFLIXIMAB, RECOMBINANT | Faecal calprotectin abnormal | 2 |
| INFLIXIMAB, RECOMBINANT | Fistula discharge | 2 |
| INFLIXIMAB, RECOMBINANT | Gastroenteritis | 2 |
| INFLIXIMAB, RECOMBINANT | Growth retardation | 2 |
| INFLIXIMAB, RECOMBINANT | Guillain-Barre syndrome | 2 |
| INFLIXIMAB, RECOMBINANT | Haematochezia | 2 |
| INFLIXIMAB, RECOMBINANT | Hepatosplenic T-cell lymphoma | 2 |
| INFLIXIMAB, RECOMBINANT | Hypersensitivity | 2 |
| INFLIXIMAB, RECOMBINANT | Ileostomy | 2 |
| INFLIXIMAB, RECOMBINANT | Immune thrombocytopenic purpura | 2 |
| INFLIXIMAB, RECOMBINANT | Intestinal operation | 2 |
| INFLIXIMAB, RECOMBINANT | Intestinal resection | 2 |
| INFLIXIMAB, RECOMBINANT | Large intestinal stenosis | 2 |
Total Records: 276 Number of Pages: 14